608 related articles for article (PubMed ID: 24519768)
1. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.
Miller AB; Wall C; Baines CJ; Sun P; To T; Narod SA
BMJ; 2014 Feb; 348():g366. PubMed ID: 24519768
[TBL] [Abstract][Full Text] [Related]
2. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
[TBL] [Abstract][Full Text] [Related]
3. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
[TBL] [Abstract][Full Text] [Related]
4. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
5. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
Miller AB; To T; Baines CJ; Wall C
J Natl Cancer Inst; 2000 Sep; 92(18):1490-9. PubMed ID: 10995804
[TBL] [Abstract][Full Text] [Related]
6. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.
Miller AB; To T; Baines CJ; Wall C
Ann Intern Med; 2002 Sep; 137(5 Part 1):305-12. PubMed ID: 12204013
[TBL] [Abstract][Full Text] [Related]
7. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract][Full Text] [Related]
9. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.
Mittra I; Mishra GA; Dikshit RP; Gupta S; Kulkarni VY; Shaikh HKA; Shastri SS; Hawaldar R; Gupta S; Pramesh CS; Badwe RA
BMJ; 2021 Feb; 372():n256. PubMed ID: 33627312
[TBL] [Abstract][Full Text] [Related]
10. The Canadian National Breast Screening Study: update on breast cancer mortality.
Miller AB; To T; Baines CJ; Wall C
J Natl Cancer Inst Monogr; 1997; (22):37-41. PubMed ID: 9709273
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
[TBL] [Abstract][Full Text] [Related]
12. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
13. Re: "Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial".
Weiss NS
Am J Epidemiol; 2014 Oct; 180(7):759-60. PubMed ID: 25194149
[No Abstract] [Full Text] [Related]
14. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
15. The Canadian National Breast Screening Study: a perspective on criticisms.
Baines CJ
Ann Intern Med; 1994 Feb; 120(4):326-34. PubMed ID: 8291826
[TBL] [Abstract][Full Text] [Related]
16. Revised estimates of overdiagnosis from the Canadian National Breast Screening Study.
Baines CJ; To T; Miller AB
Prev Med; 2016 Sep; 90():66-71. PubMed ID: 27374944
[TBL] [Abstract][Full Text] [Related]
17. MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial.
Saadatmand S; Geuzinge HA; Rutgers EJT; Mann RM; de Roy van Zuidewijn DBW; Zonderland HM; Tollenaar RAEM; Lobbes MBI; Ausems MGEM; van 't Riet M; Hooning MJ; Mares-Engelberts I; Luiten EJT; Heijnsdijk EAM; Verhoef C; Karssemeijer N; Oosterwijk JC; Obdeijn IM; de Koning HJ; Tilanus-Linthorst MMA;
Lancet Oncol; 2019 Aug; 20(8):1136-1147. PubMed ID: 31221620
[TBL] [Abstract][Full Text] [Related]
18. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.
Moss SM; Wale C; Smith R; Evans A; Cuckle H; Duffy SW
Lancet Oncol; 2015 Sep; 16(9):1123-1132. PubMed ID: 26206144
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast Cancers.
Niraula S; Biswanger N; Hu P; Lambert P; Decker K
JAMA Netw Open; 2020 Sep; 3(9):e2018179. PubMed ID: 32975573
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial of digital breast tomosynthesis vs digital mammography as primary screening tests: Screening results over subsequent episodes of the Proteus Donna study.
Armaroli P; Frigerio A; Correale L; Ponti A; Artuso F; Casella D; Falco P; Favettini E; Fonio P; Giordano L; Marra V; Milanesio L; Morra L; Presti P; Riggi E; Vergini V; Segnan N
Int J Cancer; 2022 Nov; 151(10):1778-1790. PubMed ID: 35689673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]